U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for ANDA 204621

Expand all

NEVIRAPINE (NEVIRAPINE)
100MG
Marketing Status: Discontinued
Active Ingredient: NEVIRAPINE
Proprietary Name: NEVIRAPINE
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 100MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A204621
Product Number: 002
Approval Date: Nov 9, 2015
Applicant Holder Full Name: ALVOGEN INC
Marketing Status:  Discontinued
Patent and Exclusivity Information
NEVIRAPINE (NEVIRAPINE)
400MG
Marketing Status: Discontinued
Active Ingredient: NEVIRAPINE
Proprietary Name: NEVIRAPINE
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 400MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A204621
Product Number: 001
Approval Date: Jul 10, 2015
Applicant Holder Full Name: ALVOGEN INC
Marketing Status:  Discontinued
Patent and Exclusivity Information
Back to Top